A new study suggests that biotech companies are spending far less than believed on research and development for approved drugs, despite rising prices.
By GINA KOLATA from NYT Health http://ift.tt/2vPB8zT
via IFTTT
Drugs (Pharmaceuticals), Cancer
Source The New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét